A pilot study to investigate the effects of pentosan polysulfate sodium in Ross River virus induced arthralgia
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2018
At a glance
- Drugs Pentosan polysulfate (Primary)
- Indications Arthralgia; Ross River virus infections
- Focus Adverse reactions
- Acronyms PARA_004
- Sponsors Paradigm Biopharma
- 29 Aug 2018 Planned End Date changed from 10 May 2018 to 20 Nov 2018.
- 29 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 13 Jul 2017 Planned initiation date changed from 10 Jul 2017 to 20 Jul 2017.